European Haemophilia Consortium: Day 1 At EHC Conference 2025 In Vienna – What A Start
European Haemophilia Consortium (EHC) posted on LinkedIn:
”Day 1 at EHC Conference 2025 in Vienna – What a Start
We kicked off with insights into haemophilia care in Austria, celebrating six decades of advocacy from Österreichische Hämophilie Gesellschaft (ÖHG), the Austrian Haemophilia Society, and learning from their national registry and treatment guidelines.
A powerful session on women’s health and bleeding disorders broke down barriers with discussions on diagnosis, menopausal management, and inspiring patient perspectives from symptomatic carriers.
The afternoon dove deep into von Willebrand Disease, exploring family mental health, the latest in genetics and screening, and a sneak peek at future treatments.
The day wrapped up with our General Assembly, where EHC National Member Organisation representatives came together for important discussions and decisions about our community’s future.
Thank you to our brilliant chairs, speakers, and all attendees. Looking forward to tomorrow’s sessions.”
Keep up with Hemostasis Today.
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids
-
Apr 14, 2026, 16:56Saskia Middeldorp: Key Takeaways from the 2026 ACC/AHA Guideline on Acute PE
-
Apr 14, 2026, 16:54Chokri Ben Lamine: Extracorporeal Photopheresis for aGVHD cGVHD Post-SCT – 50 Pearls
-
Apr 14, 2026, 16:49Ahmed Magdi Omar: Key Takeaways From the Latest 2026 Guidelines on Antiplatelet Therapy in AIS